BioPharmSignal logoBioPharmSignal

Biotech News

iSpecimen Secures Suppliers for COVID-style hMPV Outbreak

iSpecimen (ISPC)iSpecimenCompany update

Woburn, Massachusetts--(Newsfile Corp. - January 16, 2025) - iSpecimen Inc. (NASDAQ: ISPC), a leading online marketplace for human biospecimens, has secured suppliers for the flu-like human metapneumovirus (hMPV). The virus has been causing hospitals in China to become overrun, raising the potential for another...

Related news

ISPCiSpecimen2024-09-26 07:30 EST

iSpecimen Secures $1 Million Loan; Appoints Three New Board Members

ISPCiSpecimen2023-07-06 07:30 EST

Thirteen New Biospecimen Suppliers Added to iSpecimen's Proprietary Provider Network

View all latest news

iSpecimen

iSpecimen is a healthcare data and biospecimen marketplace company that connects researchers with human biospecimens and related services. Its role is to support research and translational work rather than develop therapies.

Recent company news

ISPCiSpecimen2025-01-16 16:01 EST

iSpecimen Secures Suppliers for COVID-style hMPV Outbreak

ISPCiSpecimen2024-12-20 08:30 EST

iSpecimen Will Serve as a Preferred Provider of Cancer Biospecimens

ISPCiSpecimen2024-12-13 07:30 EST

iSpecimen Reports Positive Results on Next Day Quote Program for Researchers and Providers

ISPCiSpecimen2024-12-12 17:11 EST

iSpecimen Appoints Robert Lim as CEO and Director

ISPCiSpecimen2024-11-08 07:30 EST

iSpecimen Named Top Competitor in $4.4 Billion USD Market

Stock data

Close
2.20 USD
Market cap
4.41M USD
Exchange
NASDAQ
Sector
Biopharma
Location
United States